US2003211153A1PendingUtilityA1
Composition for sustained release of human growth hormone
Priority: Dec 2, 1992Filed: Oct 29, 2002Published: Nov 13, 2003
Est. expiryDec 2, 2012(expired)· nominal 20-yr term from priority
A61K 9/1611A61K 38/27B82Y 5/00Y10S530/839A61K 9/1694A61K 9/1647A61K 9/16Y10T428/2985
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A pharmaceutical composition for the sustained release of human growth hormone from a polymer matrix is disclosed. The pharmaceutical composition comprises a biocompatible polymer, particles of metal cation-complexed human growth hormone wherein said particles are dispersed within the biocompatible polymer and an aqueous injection vehicle.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A pharmaceutical composition for the sustained release of human growth hormone from a polymer matrix, comprising:
a) a biocompatible polymer; b) particles of metal cation-complexed human growth hormone, wherein said particles are dispersed within the biocompatible polymer; and c) an aqueous injection vehicle.Join the waitlist — get patent alerts
Track US2003211153A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.